城建發展(600266.SH)擬分期發行總額不超58億元公司債券
格隆匯4月23日丨城建發展(600266.SH)披露面向專業投資者公開發行公司債券預案,此次發行的公司債券票面總額不超過58億元(含58億元)人民幣,分期發行。具體發行規模及分期方式提請股東大會授權董事會根據公司資金需求情況和市場情況確定。
期限不超過5年(含5年),可以為單一期限品種,也可以為多種期限的混合品種。具體期限方案、含權條款設計提請股東大會授權董事會根據公司資金需求情況和市場情況確定。
募集資金擬用於償還行權回售的公司債券及其他債務,以及法律法規允許的其他用途。具體用途提請股東大會授權董事會根據公司財務狀況確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.